The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ophthalmic Therapeutics/Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Ophthalmic Therapeutics/Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ophthalmic Therapeutics/Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dry Eye accounting for % of the Ophthalmic Therapeutics/Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-allergy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ophthalmic Therapeutics/Drug include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, and Merck Sharp & Dohme Corp., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ophthalmic Therapeutics/Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Market segment by Application, can be divided into
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
Market segment by players, this report covers
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ophthalmic Therapeutics/Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ophthalmic Therapeutics/Drug, with revenue, gross margin and global market share of Ophthalmic Therapeutics/Drug from 2019 to 2022.
Chapter 3, the Ophthalmic Therapeutics/Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmic Therapeutics/Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ophthalmic Therapeutics/Drug research findings and conclusion, appendix and data source.
Geographical Area
Global
The Ophthalmic Therapeutics/Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ophthalmic Therapeutics/Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dry Eye accounting for % of the Ophthalmic Therapeutics/Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-allergy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ophthalmic Therapeutics/Drug include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, and Merck Sharp & Dohme Corp., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ophthalmic Therapeutics/Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Market segment by Application, can be divided into
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
Market segment by players, this report covers
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ophthalmic Therapeutics/Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ophthalmic Therapeutics/Drug, with revenue, gross margin and global market share of Ophthalmic Therapeutics/Drug from 2019 to 2022.
Chapter 3, the Ophthalmic Therapeutics/Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmic Therapeutics/Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ophthalmic Therapeutics/Drug research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Ophthalmic Therapeutics/Drug
1.2 Classification of Ophthalmic Therapeutics/Drug by Type
1.2.1 Overview: Global Ophthalmic Therapeutics/Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type in 2021
1.2.3 Anti-allergy
1.2.4 Anti-VEGF Agents
1.2.5 Anti-inflammatory
1.2.6 Anti-glaucoma
1.2.7 Others
1.3 Global Ophthalmic Therapeutics/Drug Market by Application
1.3.1 Overview: Global Ophthalmic Therapeutics/Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dry Eye
1.3.3 Allergies
1.3.4 Glaucoma
1.3.5 Infection
1.3.6 Retinal Disorders
1.3.7 Uveitis
1.3.8 Others
1.4 Global Ophthalmic Therapeutics/Drug Market Size & Forecast
1.5 Global Ophthalmic Therapeutics/Drug Market Size and Forecast by Region
1.5.1 Global Ophthalmic Therapeutics/Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Ophthalmic Therapeutics/Drug Market Size by Region, (2017-2022)
1.5.3 North America Ophthalmic Therapeutics/Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Ophthalmic Therapeutics/Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size and Prospect (2017-2028)
1.5.6 South America Ophthalmic Therapeutics/Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Ophthalmic Therapeutics/Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Therapeutics/Drug Market Drivers
1.6.2 Ophthalmic Therapeutics/Drug Market Restraints
1.6.3 Ophthalmic Therapeutics/Drug Trends Analysis
2 Company Profiles
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business
2.1.3 Alcon Ophthalmic Therapeutics/Drug Product and Solutions
2.1.4 Alcon Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alcon Recent Developments and Future Plans
2.2 Johnson and Johnson Vision Care, Inc.
2.2.1 Johnson and Johnson Vision Care, Inc. Details
2.2.2 Johnson and Johnson Vision Care, Inc. Major Business
2.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
2.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Johnson and Johnson Vision Care, Inc. Recent Developments and Future Plans
2.3 Bausch & Lomb Incorporated
2.3.1 Bausch & Lomb Incorporated Details
2.3.2 Bausch & Lomb Incorporated Major Business
2.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product and Solutions
2.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bausch & Lomb Incorporated Recent Developments and Future Plans
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Ophthalmic Therapeutics/Drug Product and Solutions
2.4.4 Novartis AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Novartis AG Recent Developments and Future Plans
2.5 Merck Sharp & Dohme Corp.
2.5.1 Merck Sharp & Dohme Corp. Details
2.5.2 Merck Sharp & Dohme Corp. Major Business
2.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product and Solutions
2.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck Sharp & Dohme Corp. Recent Developments and Future Plans
2.6 Regeneron Pharmaceuticals Inc.
2.6.1 Regeneron Pharmaceuticals Inc. Details
2.6.2 Regeneron Pharmaceuticals Inc. Major Business
2.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product and Solutions
2.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Regeneron Pharmaceuticals Inc. Recent Developments and Future Plans
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Ophthalmic Therapeutics/Drug Product and Solutions
2.7.4 Allergan Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Allergan Recent Developments and Future Plans
2.8 Pfizer Inc.
2.8.1 Pfizer Inc. Details
2.8.2 Pfizer Inc. Major Business
2.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Product and Solutions
2.8.4 Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pfizer Inc. Recent Developments and Future Plans
2.9 Valeant
2.9.1 Valeant Details
2.9.2 Valeant Major Business
2.9.3 Valeant Ophthalmic Therapeutics/Drug Product and Solutions
2.9.4 Valeant Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Valeant Recent Developments and Future Plans
2.10 Bayer AG
2.10.1 Bayer AG Details
2.10.2 Bayer AG Major Business
2.10.3 Bayer AG Ophthalmic Therapeutics/Drug Product and Solutions
2.10.4 Bayer AG Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bayer AG Recent Developments and Future Plans
2.11 Santen Pharmaceuticals Co. Ltd
2.11.1 Santen Pharmaceuticals Co. Ltd Details
2.11.2 Santen Pharmaceuticals Co. Ltd Major Business
2.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product and Solutions
2.11.4 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Santen Pharmaceuticals Co. Ltd Recent Developments and Future Plans
2.12 Genentech, Inc.
2.12.1 Genentech, Inc. Details
2.12.2 Genentech, Inc. Major Business
2.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
2.12.4 Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Genentech, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ophthalmic Therapeutics/Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Ophthalmic Therapeutics/Drug Players Market Share in 2021
3.2.2 Top 10 Ophthalmic Therapeutics/Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Ophthalmic Therapeutics/Drug Players Head Office, Products and Services Provided
3.4 Ophthalmic Therapeutics/Drug Mergers & Acquisitions
3.5 Ophthalmic Therapeutics/Drug New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ophthalmic Therapeutics/Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Ophthalmic Therapeutics/Drug Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2017-2022)
5.2 Global Ophthalmic Therapeutics/Drug Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Ophthalmic Therapeutics/Drug Revenue by Type (2017-2028)
6.2 North America Ophthalmic Therapeutics/Drug Revenue by Application (2017-2028)
6.3 North America Ophthalmic Therapeutics/Drug Market Size by Country
6.3.1 North America Ophthalmic Therapeutics/Drug Revenue by Country (2017-2028)
6.3.2 United States Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Ophthalmic Therapeutics/Drug Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Therapeutics/Drug Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Country
7.3.1 Europe Ophthalmic Therapeutics/Drug Revenue by Country (2017-2028)
7.3.2 Germany Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
7.3.3 France Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region
8.3.1 Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Region (2017-2028)
8.3.2 China Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8.3.5 India Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Ophthalmic Therapeutics/Drug Revenue by Type (2017-2028)
9.2 South America Ophthalmic Therapeutics/Drug Revenue by Application (2017-2028)
9.3 South America Ophthalmic Therapeutics/Drug Market Size by Country
9.3.1 South America Ophthalmic Therapeutics/Drug Revenue by Country (2017-2028)
9.3.2 Brazil Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country
10.3.1 Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Country (2017-2028)
10.3.2 Turkey Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Ophthalmic Therapeutics/Drug Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Ophthalmic Therapeutics/Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Ophthalmic Therapeutics/Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Ophthalmic Therapeutics/Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) by Region (2017-2022)
Table 5. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Region (2023-2028)
Table 6. Alcon Corporate Information, Head Office, and Major Competitors
Table 7. Alcon Major Business
Table 8. Alcon Ophthalmic Therapeutics/Drug Product and Solutions
Table 9. Alcon Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Johnson and Johnson Vision Care, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Johnson and Johnson Vision Care, Inc. Major Business
Table 12. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 13. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bausch & Lomb Incorporated Corporate Information, Head Office, and Major Competitors
Table 15. Bausch & Lomb Incorporated Major Business
Table 16. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product and Solutions
Table 17. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Ophthalmic Therapeutics/Drug Product and Solutions
Table 21. Novartis AG Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck Sharp & Dohme Corp. Corporate Information, Head Office, and Major Competitors
Table 23. Merck Sharp & Dohme Corp. Major Business
Table 24. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product and Solutions
Table 25. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Regeneron Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Regeneron Pharmaceuticals Inc. Major Business
Table 28. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 29. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Allergan Corporate Information, Head Office, and Major Competitors
Table 31. Allergan Major Business
Table 32. Allergan Ophthalmic Therapeutics/Drug Product and Solutions
Table 33. Allergan Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Inc. Major Business
Table 36. Pfizer Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 37. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Valeant Corporate Information, Head Office, and Major Competitors
Table 39. Valeant Major Business
Table 40. Valeant Ophthalmic Therapeutics/Drug Product and Solutions
Table 41. Valeant Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 43. Bayer AG Major Business
Table 44. Bayer AG Ophthalmic Therapeutics/Drug Product and Solutions
Table 45. Bayer AG Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Santen Pharmaceuticals Co. Ltd Corporate Information, Head Office, and Major Competitors
Table 47. Santen Pharmaceuticals Co. Ltd Major Business
Table 48. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product and Solutions
Table 49. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Genentech, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Genentech, Inc. Major Business
Table 52. Genentech, Inc. Ophthalmic Therapeutics/Drug Product and Solutions
Table 53. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Ophthalmic Therapeutics/Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Ophthalmic Therapeutics/Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Ophthalmic Therapeutics/Drug Players Head Office, Products and Services Provided
Table 58. Ophthalmic Therapeutics/Drug Mergers & Acquisitions in the Past Five Years
Table 59. Ophthalmic Therapeutics/Drug New Entrants and Expansion Plans
Table 60. Global Ophthalmic Therapeutics/Drug Revenue (USD Million) by Type (2017-2022)
Table 61. Global Ophthalmic Therapeutics/Drug Revenue Share by Type (2017-2022)
Table 62. Global Ophthalmic Therapeutics/Drug Revenue Forecast by Type (2023-2028)
Table 63. Global Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022)
Table 64. Global Ophthalmic Therapeutics/Drug Revenue Forecast by Application (2023-2028)
Table 65. North America Ophthalmic Therapeutics/Drug Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Ophthalmic Therapeutics/Drug Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Ophthalmic Therapeutics/Drug Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Ophthalmic Therapeutics/Drug Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Ophthalmic Therapeutics/Drug Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Ophthalmic Therapeutics/Drug Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Ophthalmic Therapeutics/Drug Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Ophthalmic Therapeutics/Drug Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Ophthalmic Therapeutics/Drug Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Ophthalmic Therapeutics/Drug Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Ophthalmic Therapeutics/Drug Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Ophthalmic Therapeutics/Drug Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Ophthalmic Therapeutics/Drug Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Ophthalmic Therapeutics/Drug Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Ophthalmic Therapeutics/Drug Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Ophthalmic Therapeutics/Drug Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Ophthalmic Therapeutics/Drug Picture
Figure 2. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type in 2021
Figure 3. Anti-allergy
Figure 4. Anti-VEGF Agents
Figure 5. Anti-inflammatory
Figure 6. Anti-glaucoma
Figure 7. Others
Figure 8. Ophthalmic Therapeutics/Drug Revenue Market Share by Application in 2021
Figure 9. Dry Eye Picture
Figure 10. Allergies Picture
Figure 11. Glaucoma Picture
Figure 12. Infection Picture
Figure 13. Retinal Disorders Picture
Figure 14. Uveitis Picture
Figure 15. Others Picture
Figure 16. Global Ophthalmic Therapeutics/Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 17. Global Ophthalmic Therapeutics/Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Region (2017-2028)
Figure 19. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Region in 2021
Figure 20. North America Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Europe Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. South America Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Ophthalmic Therapeutics/Drug Market Drivers
Figure 26. Ophthalmic Therapeutics/Drug Market Restraints
Figure 27. Ophthalmic Therapeutics/Drug Market Trends
Figure 28. Alcon Recent Developments and Future Plans
Figure 29. Johnson and Johnson Vision Care, Inc. Recent Developments and Future Plans
Figure 30. Bausch & Lomb Incorporated Recent Developments and Future Plans
Figure 31. Novartis AG Recent Developments and Future Plans
Figure 32. Merck Sharp & Dohme Corp. Recent Developments and Future Plans
Figure 33. Regeneron Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 34. Allergan Recent Developments and Future Plans
Figure 35. Pfizer Inc. Recent Developments and Future Plans
Figure 36. Valeant Recent Developments and Future Plans
Figure 37. Bayer AG Recent Developments and Future Plans
Figure 38. Santen Pharmaceuticals Co. Ltd Recent Developments and Future Plans
Figure 39. Genentech, Inc. Recent Developments and Future Plans
Figure 40. Global Ophthalmic Therapeutics/Drug Revenue Share by Players in 2021
Figure 41. Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Ophthalmic Therapeutics/Drug Revenue Market Share in 2021
Figure 43. Global Top 10 Players Ophthalmic Therapeutics/Drug Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Ophthalmic Therapeutics/Drug Revenue Share by Type in 2021
Figure 46. Global Ophthalmic Therapeutics/Drug Market Share Forecast by Type (2023-2028)
Figure 47. Global Ophthalmic Therapeutics/Drug Revenue Share by Application in 2021
Figure 48. Global Ophthalmic Therapeutics/Drug Market Share Forecast by Application (2023-2028)
Figure 49. North America Ophthalmic Therapeutics/Drug Sales Market Share by Type (2017-2028)
Figure 50. North America Ophthalmic Therapeutics/Drug Sales Market Share by Application (2017-2028)
Figure 51. North America Ophthalmic Therapeutics/Drug Revenue Market Share by Country (2017-2028)
Figure 52. United States Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Ophthalmic Therapeutics/Drug Sales Market Share by Type (2017-2028)
Figure 56. Europe Ophthalmic Therapeutics/Drug Sales Market Share by Application (2017-2028)
Figure 57. Europe Ophthalmic Therapeutics/Drug Revenue Market Share by Country (2017-2028)
Figure 58. Germany Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Ophthalmic Therapeutics/Drug Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Ophthalmic Therapeutics/Drug Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Ophthalmic Therapeutics/Drug Revenue Market Share by Region (2017-2028)
Figure 66. China Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Ophthalmic Therapeutics/Drug Sales Market Share by Type (2017-2028)
Figure 73. South America Ophthalmic Therapeutics/Drug Sales Market Share by Application (2017-2028)
Figure 74. South America Ophthalmic Therapeutics/Drug Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
